NORTHERN TRUST CORP - MEI PHARMA INC ownership

MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 105 filers reported holding MEI PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of MEI PHARMA INC
ValueSharesWeighting
Q1 2023$48,424
-7.4%
211,551
-1.4%
0.00%
Q4 2022$52,287
-37.0%
214,6440.0%0.00%
Q3 2022$83,000
-36.2%
214,644
-0.3%
0.00%
Q2 2022$130,000
-80.3%
215,317
-80.3%
0.00%
Q1 2022$659,000
-75.1%
1,094,164
+10.5%
0.00%
Q4 2021$2,645,000
-8.0%
990,614
-4.9%
0.00%
-100.0%
Q3 2021$2,874,000
-3.7%
1,041,571
-0.5%
0.00%0.0%
Q2 2021$2,983,000
-20.2%
1,046,724
-3.9%
0.00%0.0%
Q1 2021$3,736,000
+21.2%
1,089,166
-6.7%
0.00%0.0%
Q4 2020$3,082,000
-13.6%
1,167,280
+2.1%
0.00%0.0%
Q3 2020$3,566,000
-28.3%
1,142,835
-5.1%
0.00%0.0%
Q2 2020$4,972,000
+175.0%
1,204,058
+7.3%
0.00%0.0%
Q1 2020$1,808,000
-0.1%
1,122,639
+53.9%
0.00%
Q4 2019$1,810,000
+49.8%
729,593
+1.4%
0.00%
Q3 2019$1,208,000
+305.4%
719,568
+504.6%
0.00%
Q2 2019$298,000
+56.8%
119,007
+92.6%
0.00%
Q1 2019$190,000
+16.6%
61,7960.0%0.00%
Q4 2018$163,000
-41.2%
61,796
-3.8%
0.00%
Q3 2018$277,000
+7.4%
64,207
-1.8%
0.00%
Q2 2018$258,000
+85.6%
65,383
-2.8%
0.00%
Q1 2018$139,000
-9.7%
67,281
-8.3%
0.00%
Q4 2017$154,000
-21.8%
73,4040.0%0.00%
Q3 2017$197,000
+12.6%
73,4040.0%0.00%
Q2 2017$175,000
+47.1%
73,4040.0%0.00%
Q1 2017$119,000
+45.1%
73,404
+29.4%
0.00%
Q4 2016$82,000
-16.3%
56,717
+2.2%
0.00%
Q3 2016$98,000
+104.2%
55,477
+56.6%
0.00%
Q2 2016$48,000
+6.7%
35,4290.0%0.00%
Q1 2016$45,000
-21.1%
35,4290.0%0.00%
Q4 2015$57,000
+1.8%
35,4290.0%0.00%
Q3 2015$56,000
-8.2%
35,4290.0%0.00%
Q2 2015$61,000
-20.8%
35,429
-17.3%
0.00%
Q1 2015$77,000
-33.0%
42,841
+58.4%
0.00%
Q4 2014$115,000
-38.5%
27,0410.0%0.00%
Q3 2014$187,000
-72.6%
27,041
-74.9%
0.00%
Q2 2014$683,000
-54.3%
107,761
-19.7%
0.00%
Q1 2014$1,494,000
+24.2%
134,146
-10.7%
0.00%
Q4 2013$1,203,000
-7.9%
150,151
+29.4%
0.00%
Q3 2013$1,306,000
+404.2%
116,071
+219.7%
0.00%
Q2 2013$259,00036,3110.00%
Other shareholders
MEI PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Burrage Capital Management LLC 3,039,038$9,482,0007.48%
Asymmetry Capital Management, L.P. 787,359$2,457,0001.58%
First Light Asset Management, LLC 3,763,804$11,743,0001.20%
NEA Management Company, LLC 8,533,072$26,623,0001.13%
Opaleye Management Inc. 1,556,000$4,855,0000.95%
BVF INC/IL 4,080,162$12,730,0000.69%
DAFNA Capital Management LLC 666,000$2,078,0000.68%
CAXTON CORP 175,560$548,0000.52%
Alambic Investment Management, L.P. 12,500$39,0000.43%
Boxer Capital, LLC 2,913,091$9,089,0000.31%
View complete list of MEI PHARMA INC shareholders